Patient satisfaction after switching from a monthly to a quarterly administered long-acting injectables: A case series

被引：0
|
作者：
Pardo de Santayana, G. [1 ]
机构：
[1] Hosp Univ Marques De Valdecilla, Psychiat, Santander, Spain
来源：
EUROPEAN PSYCHIATRY | 2018年 / 48卷
关键词：
D O I：
暂无
中图分类号：
R749 [精神病学];
学科分类号：
100205 ;
摘要：
EV0698
引用
收藏
页码：S504 / S504
页数：1
相关论文
共 50 条
  • [1] A Case of Tardive Dyskinesia that Regressed After Switching From Risperidone Long-Acting Injectable to Paliperidone 1-Monthly Long-Acting Injectable
    Gokcay, Hasan
    Takim, Ugur
    AMERICAN JOURNAL OF THERAPEUTICS, 2024, 31 (06)
  • [2] Switching from Monthly to Three-Monthly Long-Acting Injectable Paliperidone: A Survey on Subjective Satisfaction and Safety
    Barnett, Joshua
    Pappa, Sofia
    PATIENT PREFERENCE AND ADHERENCE, 2023, 17 : 1603 - 1610
  • [3] Optimizing Treatment of Schizophrenia: Clinical and Economical Potential for Patient Switching to Long-Acting Injectables
    Zaniolo, Orietta
    Maffezzoli, Silvia
    Povero, Massimiliano
    Pradelli, Lorenzo
    FARMECONOMIA-HEALTH ECONOMICS AND THERAPEUTIC PATHWAYS, 2024, 25 (01) : 9 - 17
  • [4] OPTIMIZING TREATMENT OF SCHIZOPHRENIA: PHARMACOECONOMIC CONSEQUENCES AND POTENTIAL FOR PATIENT SWITCHING TO LONG-ACTING INJECTABLES
    Zaniolo, O.
    Pradelli, L.
    Franchi, A.
    Maffezzoli, S.
    VALUE IN HEALTH, 2023, 26 (12) : S146 - S146
  • [5] Improving patient acceptance of maintenance treatment with long-acting injectables
    Potkin, S.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2019, 29 : S617 - S617
  • [6] Current State and Opportunities with Long-acting Injectables: Industry Perspectives from the Innovation and Quality Consortium “Long-Acting Injectables” Working Group
    Andrea Bauer
    Philippe Berben
    Sudhir S. Chakravarthi
    Sayantan Chattorraj
    Ashish Garg
    Betty Gourdon
    Tycho Heimbach
    Ye Huang
    Christopher Morrison
    Deepak Mundhra
    Ramesh Palaparthy
    Pratik Saha
    Maxime Siemons
    Naveed A. Shaik
    Yi Shi
    Sara Shum
    Naveen K. Thakral
    Shweta Urva
    Ryan Vargo
    Venkat R. Koganti
    Stephanie E. Barrett
    Pharmaceutical Research, 2023, 40 : 1601 - 1631
  • [7] Current State and Opportunities with Long-acting Injectables: Industry Perspectives from the Innovation and Quality Consortium "Long-Acting Injectables" Working Group
    Bauer, Andrea
    Berben, Philippe
    Chakravarthi, Sudhir S.
    Chattorraj, Sayantan
    Garg, Ashish
    Gourdon, Betty
    Heimbach, Tycho
    Huang, Ye
    Morrison, Christopher
    Mundhra, Deepak
    Palaparthy, Ramesh
    Saha, Pratik
    Siemons, Maxime
    Shaik, Naveed A.
    Shi, Yi
    Shum, Sara
    Thakral, Naveen K.
    Urva, Shweta
    Vargo, Ryan
    Koganti, Venkat R.
    Barrett, Stephanie E.
    PHARMACEUTICAL RESEARCH, 2023, 40 (07) : 1601 - 1631
  • [8] Evaluating patient satisfaction with pharmacist-administered long-acting injectable antipsychotics in the community pharmacy
    Mooney, Emanuela V.
    Hamper, Jeffrey G.
    Willis, Robert T.
    Farinha, Tonna L.
    Ricchetti, Charlotte A.
    JOURNAL OF THE AMERICAN PHARMACISTS ASSOCIATION, 2018, 58 (04) : S24 - +
  • [9] The modern perspective for long-acting injectables antipsychotics in the patient-centered care of schizophrenia
    Pietrini, Francesco
    Albert, Umberto
    Ballerini, Andrea
    Calo, Paola
    Maina, Giuseppe
    Pinna, Federica
    Vaggi, Marco
    Boggian, Ileana
    Fontana, Maria
    Moro, Cesare
    Carpiniello, Bernardo
    NEUROPSYCHIATRIC DISEASE AND TREATMENT, 2019, 15 : 1045 - 1060
  • [10] Compliance, therapeutic alliance and patient satisfaction with long-acting risperidone
    Schreiner, A
    Pajonk, FG
    EUROPEAN PSYCHIATRY, 2005, 20 : S77 - S77
12345